10-K/A: NorthStar Healthcare Income Files Amended 10-K to Correct Internal Control Reporting Omission

NorthStar Healthcare Income filed an amendment to its annual report to include management's report on internal control over financial reporting, which was inadvertently omitted from the original filing.

Summary

• NorthStar Healthcare Income, Inc. filed an amendment to its original 10-K annual report for the year ended December 31, 2023.
• The amendment, filed on Form 10-K/A, corrects the omission of management's report on internal control over financial reporting.
• The original 10-K was filed on March 22, 2024, and this amendment was filed on October 24, 2024.
• The company's management has concluded that their disclosure controls and procedures are effective at a reasonable assurance level as of December 31, 2023.
• There were no changes in internal control over financial reporting during the most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting.
• The company has 185,712,103 shares of common stock outstanding as of March 21, 2024.

Sentiment

Score: 7

Explanation: The document is primarily a compliance filing to correct an omission. The sentiment is neutral to slightly positive as the company has taken steps to rectify the issue and has confirmed the effectiveness of its controls.

Positives

• The company has corrected the omission of management's report on internal control over financial reporting.
• Management has assessed and concluded that the company's disclosure controls and procedures are effective.
• There were no material changes to internal control over financial reporting during the most recent fiscal quarter.

Negatives

• The original 10-K filing had an inadvertent omission, requiring an amendment.

Risks

• The document acknowledges that internal control systems, no matter how well designed, can only provide reasonable, not absolute, assurance against errors or fraud.
• Projections of the effectiveness of controls to future periods are subject to the risk of changes in conditions or deterioration in compliance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Management Comments

• Management is responsible for establishing and maintaining adequate internal control over financial reporting.
• Management has concluded that the company's disclosure controls and procedures are effective at the reasonable assurance level.
• Management does not expect that the disclosure controls and procedures or internal control over financial reporting will prevent or detect all error and all fraud.

Industry Context

This filing is a standard regulatory requirement for publicly traded companies and is not specific to the healthcare industry. The focus on internal controls is a common theme in corporate governance and financial reporting.

Comparison to Industry Standards

• The company's assessment of internal controls is consistent with the requirements of the Sarbanes-Oxley Act and SEC regulations, which are standard for all publicly traded companies in the US.
• The use of the COSO framework for internal control is a widely accepted industry practice.
• The company's disclosure controls and procedures are designed to ensure compliance with SEC rules, which is a standard practice for all public companies.

Stakeholder Impact

• The correction of the omission in the 10-K filing should reassure shareholders about the company's commitment to accurate financial reporting.
• The confirmation of effective internal controls should provide confidence to investors and other stakeholders.

Key Dates

Keywords

internal control, financial reporting, 10-K, amendment, disclosure controls, Sarbanes-Oxley Act, healthcare, compliance